Total (n = 50) | Improver (n = 39) | Non-Improver (n = 11) | p value | |
---|---|---|---|---|
Demographic characteristics | ||||
Female | 12 (24) | 6 (15) | 6 (55) | 0.0155 |
Age | 59 (53–67) | 60 (50–65) | 59 (56–74) | 0.3187 |
Clinical characteristics | ||||
Ischemic stroke | 46 (92) | 37 (95) | 9 (82) | 0.2069 |
Baseline NIHSS | 4 (2–6) | 4 (1.5–6) | 3 (2.25–4.75) | 0.6984 |
Baseline mRS | 2 (1–2) | 2 (1–2) | 2 (1.5–2.5) | 0.3416 |
Cardiovascular risk factors | ||||
Hypertension | 42 (84) | 34 (87) | 8 (73) | 0.3533 |
Hyperlipidemia | 37 (77) | 28 (76) | 9 (82) | 0.7136 |
Diabetes mellitus | 12 (24) | 10 (26) | 2 (18) | 0.7351 |
Atrial fibrillation | 2 (5) | 2 (7) | 0 (0) | 1 |
Overweight | 20 (40) | 16 (41) | 4 (36) | 1 |
Nicotine abuse | 21 (43) | 17 (44) | 4 (40) | 1 |
Alcohol abuse | 5 (10) | 4 (10) | 1 (9) | 1 |
MoCA (at inclusion) | 25 (22–27) | 25 (23–27) | 22 (20.5–24) | 0.0252 |
IMET (at inclusion) | 35 (24.75–52) | 31 (22.5–51) | 50 (35–52) | 0.1805 |
PHQ4 (at inclusion) | 3 (1–4) | 2.5 (0.25–4) | 3 (2–4) | 0.6185 |
Motor therapy duration | 46.7 (9–100.4) | 48.3 (17.5–101.3) | 26.7 (1.7–74.4) | 0.3204 |
PROMIS-10 (at inclusion) | ||||
Physical domain | 42.3 (39.8–47.7) | 42.3 (39.8–47.7) | 42.3 (38.6–44.9) | 0.6190 |
Mental domain | 43.5 (41.1–45.8) | 43.5 (41.1–47.68) | 41.1 (38.8–44.65) | 0.1446 |